Cargando…
Regional Impact of COVID-19-Associated Pulmonary Aspergillosis (CAPA) during the First Wave
Background: Critically ill COVID-19 patients have proven to be at risk for developing invasive fungal infections. However, the incidence and impact of possible/probable COVID-19-associated pulmonary aspergillosis (CAPA) in severe COVID-19 patients varies between cohorts. We aimed to assess the incid...
Autores principales: | , , , , , , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8875881/ https://www.ncbi.nlm.nih.gov/pubmed/35205851 http://dx.doi.org/10.3390/jof8020096 |
_version_ | 1784658037876719616 |
---|---|
author | Bentvelsen, Robbert G. Arkel, Andreas L. E. Van Rijpstra, Tom A. Kant, Merijn K. M. Brugge, Simone Van Der Sar-Van Der Loth, Daan W. Van Wijngaarden, Peter Mée, Arthur W. F. Du Yick, David C. Y. Diederen, Bram M. W. Wever, Peter C. Leenders, Alexander C. A. P. Van Dommelen, Laura Groot, Klaas H. De Van den Bijllaardt, Wouter Verweij, Paul E. |
author_facet | Bentvelsen, Robbert G. Arkel, Andreas L. E. Van Rijpstra, Tom A. Kant, Merijn K. M. Brugge, Simone Van Der Sar-Van Der Loth, Daan W. Van Wijngaarden, Peter Mée, Arthur W. F. Du Yick, David C. Y. Diederen, Bram M. W. Wever, Peter C. Leenders, Alexander C. A. P. Van Dommelen, Laura Groot, Klaas H. De Van den Bijllaardt, Wouter Verweij, Paul E. |
author_sort | Bentvelsen, Robbert G. |
collection | PubMed |
description | Background: Critically ill COVID-19 patients have proven to be at risk for developing invasive fungal infections. However, the incidence and impact of possible/probable COVID-19-associated pulmonary aspergillosis (CAPA) in severe COVID-19 patients varies between cohorts. We aimed to assess the incidence, risk factors, and clinical outcome of invasive pulmonary aspergillosis in a regional cohort of COVID-19 intensive care patients. Methods: We performed a regional, multicentre, retrospective cohort study in the intensive care units (ICUs) in North Brabant, The Netherlands. We included adult patients with rt-PCR-confirmed SARS-CoV-2 infection (COVID-19), requiring mechanical ventilation for acute respiratory distress syndrome. Demographics, clinical course, biomarker value, and treatment outcomes were compared between the groups with possible/probable CAPA from the main study centre and the regional centres, and without signs of CAPA from the main study centre as controls. The primary aim was to assess the regional impact of possible/probable CAPA in COVID-19 ICU patients, measured as all-cause mortality at 30 days after ICU admission. Secondary outcomes were risk factors for developing CAPA, based on underlying host factors and to identify the value of the mycological arguments for the diagnosing of CAPA. Results: Between 1 March and 30 April 2020, we included 123 patients with severe COVID-19: 29 patients (30.9%) in the main ICU with possible/probable CAPA, and 65 (69.1%) with no signs of CAPA; 29 patients in the regional ICUs with signs of CAPA. Patients’ characteristics and risk factors did not differ for CAPA and non-CAPA patients. Patients with COPD and/or chronic steroid medication developed CAPA more frequently, although this was not statistically significant. CAPA patients were admitted to the ICU earlier, had lower PF-ratios, and more often required renal replacement therapy. All-cause 30-day mortality was significantly higher in mechanically ventilated COVID-19 patients with possible/probable CAPA 39.7% (23/58) compared to patients without evidence for CAPA 16.9% (11/65) (OR 3.2 [95% CI 1.4–7.4] p = 0.005). Conclusion: The high incidence of possible and probable CAPA in critically ill COVID-19 patients is alarming. The increase in 30-day mortality in CAPA highlights the need for active surveillance and management strategies in critically ill COVID-19 patients. |
format | Online Article Text |
id | pubmed-8875881 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2022 |
publisher | MDPI |
record_format | MEDLINE/PubMed |
spelling | pubmed-88758812022-02-26 Regional Impact of COVID-19-Associated Pulmonary Aspergillosis (CAPA) during the First Wave Bentvelsen, Robbert G. Arkel, Andreas L. E. Van Rijpstra, Tom A. Kant, Merijn K. M. Brugge, Simone Van Der Sar-Van Der Loth, Daan W. Van Wijngaarden, Peter Mée, Arthur W. F. Du Yick, David C. Y. Diederen, Bram M. W. Wever, Peter C. Leenders, Alexander C. A. P. Van Dommelen, Laura Groot, Klaas H. De Van den Bijllaardt, Wouter Verweij, Paul E. J Fungi (Basel) Article Background: Critically ill COVID-19 patients have proven to be at risk for developing invasive fungal infections. However, the incidence and impact of possible/probable COVID-19-associated pulmonary aspergillosis (CAPA) in severe COVID-19 patients varies between cohorts. We aimed to assess the incidence, risk factors, and clinical outcome of invasive pulmonary aspergillosis in a regional cohort of COVID-19 intensive care patients. Methods: We performed a regional, multicentre, retrospective cohort study in the intensive care units (ICUs) in North Brabant, The Netherlands. We included adult patients with rt-PCR-confirmed SARS-CoV-2 infection (COVID-19), requiring mechanical ventilation for acute respiratory distress syndrome. Demographics, clinical course, biomarker value, and treatment outcomes were compared between the groups with possible/probable CAPA from the main study centre and the regional centres, and without signs of CAPA from the main study centre as controls. The primary aim was to assess the regional impact of possible/probable CAPA in COVID-19 ICU patients, measured as all-cause mortality at 30 days after ICU admission. Secondary outcomes were risk factors for developing CAPA, based on underlying host factors and to identify the value of the mycological arguments for the diagnosing of CAPA. Results: Between 1 March and 30 April 2020, we included 123 patients with severe COVID-19: 29 patients (30.9%) in the main ICU with possible/probable CAPA, and 65 (69.1%) with no signs of CAPA; 29 patients in the regional ICUs with signs of CAPA. Patients’ characteristics and risk factors did not differ for CAPA and non-CAPA patients. Patients with COPD and/or chronic steroid medication developed CAPA more frequently, although this was not statistically significant. CAPA patients were admitted to the ICU earlier, had lower PF-ratios, and more often required renal replacement therapy. All-cause 30-day mortality was significantly higher in mechanically ventilated COVID-19 patients with possible/probable CAPA 39.7% (23/58) compared to patients without evidence for CAPA 16.9% (11/65) (OR 3.2 [95% CI 1.4–7.4] p = 0.005). Conclusion: The high incidence of possible and probable CAPA in critically ill COVID-19 patients is alarming. The increase in 30-day mortality in CAPA highlights the need for active surveillance and management strategies in critically ill COVID-19 patients. MDPI 2022-01-19 /pmc/articles/PMC8875881/ /pubmed/35205851 http://dx.doi.org/10.3390/jof8020096 Text en © 2022 by the authors. https://creativecommons.org/licenses/by/4.0/Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/). |
spellingShingle | Article Bentvelsen, Robbert G. Arkel, Andreas L. E. Van Rijpstra, Tom A. Kant, Merijn K. M. Brugge, Simone Van Der Sar-Van Der Loth, Daan W. Van Wijngaarden, Peter Mée, Arthur W. F. Du Yick, David C. Y. Diederen, Bram M. W. Wever, Peter C. Leenders, Alexander C. A. P. Van Dommelen, Laura Groot, Klaas H. De Van den Bijllaardt, Wouter Verweij, Paul E. Regional Impact of COVID-19-Associated Pulmonary Aspergillosis (CAPA) during the First Wave |
title | Regional Impact of COVID-19-Associated Pulmonary Aspergillosis (CAPA) during the First Wave |
title_full | Regional Impact of COVID-19-Associated Pulmonary Aspergillosis (CAPA) during the First Wave |
title_fullStr | Regional Impact of COVID-19-Associated Pulmonary Aspergillosis (CAPA) during the First Wave |
title_full_unstemmed | Regional Impact of COVID-19-Associated Pulmonary Aspergillosis (CAPA) during the First Wave |
title_short | Regional Impact of COVID-19-Associated Pulmonary Aspergillosis (CAPA) during the First Wave |
title_sort | regional impact of covid-19-associated pulmonary aspergillosis (capa) during the first wave |
topic | Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8875881/ https://www.ncbi.nlm.nih.gov/pubmed/35205851 http://dx.doi.org/10.3390/jof8020096 |
work_keys_str_mv | AT bentvelsenrobbertg regionalimpactofcovid19associatedpulmonaryaspergillosiscapaduringthefirstwave AT arkelandreaslevan regionalimpactofcovid19associatedpulmonaryaspergillosiscapaduringthefirstwave AT rijpstratoma regionalimpactofcovid19associatedpulmonaryaspergillosiscapaduringthefirstwave AT kantmerijnkm regionalimpactofcovid19associatedpulmonaryaspergillosiscapaduringthefirstwave AT bruggesimonevandersarvander regionalimpactofcovid19associatedpulmonaryaspergillosiscapaduringthefirstwave AT lothdaanw regionalimpactofcovid19associatedpulmonaryaspergillosiscapaduringthefirstwave AT vanwijngaardenpeter regionalimpactofcovid19associatedpulmonaryaspergillosiscapaduringthefirstwave AT meearthurwfdu regionalimpactofcovid19associatedpulmonaryaspergillosiscapaduringthefirstwave AT yickdavidcy regionalimpactofcovid19associatedpulmonaryaspergillosiscapaduringthefirstwave AT diederenbrammw regionalimpactofcovid19associatedpulmonaryaspergillosiscapaduringthefirstwave AT weverpeterc regionalimpactofcovid19associatedpulmonaryaspergillosiscapaduringthefirstwave AT leendersalexandercap regionalimpactofcovid19associatedpulmonaryaspergillosiscapaduringthefirstwave AT vandommelenlaura regionalimpactofcovid19associatedpulmonaryaspergillosiscapaduringthefirstwave AT grootklaashde regionalimpactofcovid19associatedpulmonaryaspergillosiscapaduringthefirstwave AT vandenbijllaardtwouter regionalimpactofcovid19associatedpulmonaryaspergillosiscapaduringthefirstwave AT verweijpaule regionalimpactofcovid19associatedpulmonaryaspergillosiscapaduringthefirstwave |